Immuron (IMRN) Equity Income (2023 - 2024)
Immuron (IMRN) posted Equity Income of -$952,173 for fiscal Q2 2025 (quarter ended Dec 31, 2024).
Powered by 
Analysis
Immuron (IMRN) Equity Income (2023 - 2024) Analysis & Trends
For FY2024 (ended Dec 31, 2024), Immuron's Equity Income came in at -$14,560.
- In prior fiscal years, Immuron's Equity Income was -$202,655 in FY2023 and -$91,736 in FY2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | - |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | - |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | -2.00 Mn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | -10.00 Mn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | - |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Immuron | 7.32 Mn | -9.83 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -952,173.23 |
| Sep 9, 2024 | -9,701.96 |
| Dec 31, 2023 | -2,111.42 |
API Access
Immuron Equity Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=equity-income&ticker=IMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "equity-income", "ticker": "IMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=equity-income&ticker=IMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();